Attachment
Gates Package, p.225 · gates:exh:00118
Page text: p.225 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023
Reference# I Agreement Type
Effective Date Expiration Dz External Parties
*Lead Pl
2019-0318
Research Collaboration Agreement
4/17/2019)
Duke University
Michail Lionakis
University of Pretoria (Universiteit van Pretoria)
2019-0333
Research Collaboration Agreement
8/14/2020}
8/14/2025] [ZA]
Hans Ackerman
Oswaldo Cruz Foundation (Fiocruz, Fundacao
2019-0350
Research Collaboration Agreement
12/6/2019]
12/6/2022|Oswaldo Cruz) [BR]
Jeffrey Cohen
Oswaldo Cruz Foundation (Fiocruz, Fundacao
2019-0350
Research Collaboration Agreement
12/6/2019]
12/6/2022| Oswaldo Cruz) [BR]
Jeffrey Cohen
2019-0407
Research Collaboration Agreement
10/15/2019]
12/1/2021] University of Notre Dame [US]
Vincent Munster
2019-0430
Research Collaboration Agreement
11/14/2019]
11/14/2022 |BIOLEGEND, National Cancer Institute (NCI/NIH)
Ronald Germain
2019-0430
Research Collaboration Agreement
11/14/2019]
11/14/2022 I BIOLEGEND, National Cancer Institute (NCI/NIH)
Ronald Germain
2019-0430
Research Collaboration Agreement
11/14/2019|
11/14/2022] BIOLEGEND, National Cancer Institute (NCI/NIH)
Ronald Germain
2019-0440
Gift
3/10/2020)
Rutgers University [US]
Clifton Barry
2019-0449
Research Collaboration Agreement
3/20/2020]
3/20/2023}Cepheid [US]
Vincent Munster
2019-0460
Research Collaboration Agreement
10/22/2019]
10/22/2022 I NOVAVAX, INC.
2019-0460
Research Collaboration Agreement
10/22/2019]
10/22/2022 I NOVAVAX, INC.
2019-0472
Research Collaboration Agreement
10/9/2019}
10/9/2024|NOVARTIS PHARMA AG
2019-0472
Research Collaboration Agreement
10/9/2019]
10/9/2024|NOVARTIS PHARMA AG
2019-0472
Research Collaboration Agreement
10/9/2019}
10/9/2024|NOVARTIS PHARMA AG
lrini Sereti
2019-0486
Research Collaboration Agreement
8/20/2019}
8/20/2022|Food and Drug Administration (FDA)
Hans Ackerman
2019-0492
Research Collaboration Agreement
6/14/2019|
Cepheid [US]
Clifton Barry
2019-0501
Gift
4/17/2020|
_6/30/2022| University of California-Berkeley
Ronald Germain
2019-0501
Gift
4/17/2020}
6/30/2022] University of California-Berkeley
Ronald Germain
2019-0503
Research Collaboration Agreement
6/3/2019)
6/3/2022] Vanderbilt University [US]
John Kash
2019-0503
Research Collaboration Agreement
6/3/2019}
6/3/2022] Vanderbilt University [US]
John Kash
University of Oxford (incl Isis Innovation, The
2019-0504
Research Collaboration Agreement
10/4/2019]
10/4/2022|Chancellor, Masters and Scholars
University of Oxford (incl Isis Innovation, The
2019-0504
Research Collaboration Agreement
10/4/2019]
10/4/2022}Chancellor, Masters and Scholars
United States Army Medical Research Institute of
2019-0521
Research Collaboration Agreement
6/12/2019]
6/12/2022|Infectious Diseases (USAMRIID)
Robert Heinzen
Broad Institute of Harvard and MIT [US], DanaFarber Cancer Institute (DFCI), Massachusetts
2019-0523
Research Collaboration Agreement
9/9/2019}
9/9/2022] General Hospital (MGH; General Hospital Corp.)
Amy Klion
2019-0528
Research Collaboration Agreement
8/20/2019]
8/20/2025|Food and Drug Administration (FDA)
Patrizia FARCI